Awarded
6505--Atorvastatin CA Tablets - Radha Pharmaceuticals
Awarded tounder 36E79723D0025 (source: SAM.gov award notice)• $72.3M
Overview
- Posted
- July 19, 2023
- Notice type
- Award Notice
Notice details
- Last updated
- Sep 9, 2025
- Award date
- Jul 18, 2023
- Award amount (SAM.gov award notice)
- $72.3M
Identifiers
- Solicitation number
- 36E79723R0015
- Notice ID
- 3634145df91448529ce1303ceb5512b2
- Award number (PIID)
- 36E79723D0025
Description
Continuation of SF-1449, Block 3: The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period. Contract Award/Effective Date: ___________________ Implementation Period: __________________________ Ordering Period (Base Year): _____________________ Offerors shall not enter information into the above fields. Continuation of SF-1449, Blocks 19 through 24: Line items 1, 3, 5, and 7 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e. 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. To be considered for award, offerors must submit a price for line items 1, 2A or 2B, 3, 4A or 4B, 5, 6A or 6B, 7, and 8A or 8B for the base year and all four option years. One award will be made in the aggregate for line items 1, 2A or 2B, 3, 4A or 4B, 5, 6A or 6B, 7, and 8A or 8B for the base year and all four option years. Offered prices shall not exceed two decimal places. Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application. Line Item 1 Atorvastatin Calcium Tablets, 10MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 229,724 Bottles $_________ $__________ Option Year One 229,724 Bottles $_________ $__________ Option Year Two 229,724 Bottles $_________ $__________ Option Year Three 229,724 Bottles $_________ $__________ Option Year Four 229,724 Bottles $_________ $__________ _____________________________________________________________________________________________ Line Item 2A Atorvastatin Calcium Tablets, 10MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 99,872 Bottles $_________ $__________ Option Year One 99,872 Bottles $_________ $__________ Option Year Two 99,872 Bottles $_________ $__________ Option Year Three 99,872 Bottles $_________ $__________ Option Year Four 99,872 Bottles $_________ $__________ OR Line Item 2B Atorvastatin Calcium Tablets, 10MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 49,936 Bottles $_________ $__________ Option Year One 49,936 Bottles $_________ $__________ Option Year Two 49,936 Bottles $_________ $__________ Option Year Three 49,936 Bottles $_________ $__________ Option Year Four 49,936 Bottles $_________ $__________ Line Item 3 Atorvastatin Calcium Tablets, 20MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 448,352 Bottles $_________ $__________ Option Year One 448,352 Bottles $_________ $__________ Option Year Two 448,352 Bottles $_________ $__________ Option Year Three 448,352 Bottles $_________ $__________ Option Year Four 448,352 Bottles $_________ $__________ Line Item 4A Atorvastatin Calcium Tablets, 20MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 177,834 Bottles $_________ $__________ Option Year One 177,834 Bottles $_________ $__________ Option Year Two 177,834 Bottles $_________ $__________ Option Year Three 177,834 Bottles $_________ $__________ Option Year Four 177,834 Bottles $_________ $__________ OR Line Item 4B Atorvastatin Calcium Tablets, 20MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 88,917 Bottles $_________ $__________ Option Year One 88,917 Bottles $_________ $__________ Option Year Two 88,917 Bottles $_________ $__________ Option Year Three 88,917 Bottles $_________ $__________ Option Year Four 88,917 Bottles $_________ $__________ ___________________________________________________________________________________________ Line Item 5 Atorvastatin Calcium Tablets, 40MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 568,269 Bottles $_________ $__________ Option Year One 568,269 Bottles $_________ $__________ Option Year Two 568,269 Bottles $_________ $__________ Option Year Three 568,269 Bottles $_________ $__________ Option Year Four 568,269 Bottles $_________ $__________ ________________________________________________________________________________________ Line Item 6A Atorvastatin Calcium Tablets, 40MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 264,822 Bottles $_________ $__________ Option Year One 264,822 Bottles $_________ $__________ Option Year Two 264,822 Bottles $_________ $__________ Option Year Three 268,822 Bottles $_________ $__________ Option Year Four 268,822 Bottles $_________ $__________ OR Line Item 6B Atorvastatin Calcium Tablets, 40MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 132,411 Bottles $_________ $__________ Option Year One 132,411 Bottles $_________ $__________ Option Year Two 132,411 Bottles $_________ $__________ Option Year Three 132,411 Bottles $_________ $__________ Option Year Four 132,411 Bottles $_________ $__________ Line Item 7 Atorvastatin Calcium Tablets, 80MG, 90 Tablets per Bottle (Unit of Use) NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 522,721 Bottles $_________ $__________ Option Year One 522,721 Bottles $_________ $__________ Option Year Two 522,721 Bottles $_________ $__________ Option Year Three 522,721 Bottles $_________ $__________ Option Year Four 522,721 Bottles $_________ $__________ ________________________________________________________________________________________ Line Item 8A Atorvastatin Calcium Tablets, 80MG, 500 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 234652 Bottles $_________ $__________ Option Year One 234,652 Bottles $_________ $__________ Option Year Two 234,652 Bottles $_________ $__________ Option Year Three 234,652 Bottles $_________ $__________ Option Year Four 234,652 Bottles $_________ $__________ OR Line Item 8B Atorvastatin Calcium Tablets, 80MG, 1,000 Tablets per Bottle NDC # __________________ ANDA#_________________ Schedule of Supplies Quantity Unit Unit Price Amount Base Year 117,326 Bottles $_________ $__________ Option Year One 117,326 Bottles $_________ $__________ Option Year Two 117,326 Bottles $_________ $__________ Option Year Three 117,326 Bottles $_________ $__________ Option Year Four 117,326 Bottles $_________ $__________
Award Overview
Award Number
36E79723D0025
Award Amount (SAM.gov award notice)
$72.3M
Award Date
Jul 18, 2023
Awardee
Awardee UEI
C1S5SQ88KY67
Original Solicitation
Notice ID: 3634145df91448529ce1303ceb5512b2
Posted Date: Jul 19, 2023
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 6, 2026
- —Signed Oct 28, 2026
- —Signed Sep 14, 2026
- —Signed Sep 11, 2026
- —Signed Sep 11, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36E79723R0015- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationApr 6, 2023
6505--Atorvastatin Calcium Tablets
- 4×SolicitationApr 25, 2023
6505--Atorvastatin Calcium Tablets
- AwardedCurrentJul 19, 2023
6505--Atorvastatin CA Tablets - Radha Pharmaceuticals
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79723R0015
Archive Date
Sep 17, 2023
Office Address
HINES, IL, 60141